Natural Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$685K Buy
16,067
+206
+1% +$11.2K 0.15% 125
2026
Q1
$995K Buy
15,861
+11,825
+293% +$946K 0.25% 86
2025
Q4
$384K Buy
4,036
+112
+3% +$11K 0.1% 187
2025
Q3
$383K Buy
3,924
+25
+0.6% +$2.59K 0.1% 164
2025
Q2
$418K Buy
3,899
+565
+17% +$57.2K 0.11% 156
2025
Q1
$336K Buy
+3,334
New +$336K 0.1% 179

Other funds holding BSX

Natural Investments's BSX Position: Q2 2026 in Review

Natural Investments increased its Boston Scientific (BSX) stake by 1.3% in Q2 2026, buying an estimated $11.2K and bringing the position to 16,067 shares worth $685K. The position accounts for 0.15% of the portfolio, ranked #125.

Natural Investments first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $995K in Q1 2026. 770 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Natural Investments held 16,067 shares of Boston Scientific worth $685K as of Q2 2026.
  • Natural Investments bought 206 Boston Scientific shares in Q2 2026, an estimated $11.2K.
  • Boston Scientific made up 0.15% of Natural Investments's portfolio in Q2 2026, its #125 holding.
  • Natural Investments first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • Natural Investments's Boston Scientific position peaked at $995K in Q1 2026.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.